Vivanza Biosciences Limited (BOM:530057)

Vivanza Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	0.65	1.17	1.67	1.41	0.55
Short-Term Investments	-	-	-	0.29	0.29	0.01
Cash & Short-Term Investments	0.65	0.65	1.17	1.96	1.7	0.56
Cash Growth	-44.14%	-44.14%	-40.30%	15.11%	203.21%	-
Accounts Receivable	-	123.83	80.59	115.39	124.79	78.4
Receivables	-	150.93	97.03	131.62	166.11	97.69
Inventory	-	35.51	22.63	20.06	24.75	24.28
Other Current Assets	-	3.46	3.01	3.77	2.98	1.98
Total Current Assets	-	190.55	123.84	157.41	195.54	124.51
Property, Plant & Equipment	-	8.01	6.99	7.05	6.8	6.82
Long-Term Investments	-	0.03	0.03	0.03	0.03	0.03
Goodwill	-	16.05	16.05	16.05	16.05	16.05
Other Intangible Assets	-	0.3	0.3	0.3	0.3	0.3
Long-Term Deferred Tax Assets	-	-	0.01	0.02	0.01	0.01
Other Long-Term Assets	-	5.93	5.93	5.93	5.93	5.93
Total Assets	-	220.87	164.53	195.01	224.77	155.62

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	71.94	26.18	82.35	95.49	54.85
Accrued Expenses	-	1.59	0.37	0.22	0.25	0.22
Short-Term Debt	-	93.15	53.17	24.88	32.77	27.36
Current Portion of Long-Term Debt	-	-	-	-	32.87	1.75
Current Income Taxes Payable	-	1.56	0.23	2.67	1.43	0.25
Current Unearned Revenue	-	0.24	5.42	4.19	6.6	3.98
Other Current Liabilities	-	0.04	6.17	7.52	0.13	6.32
Total Current Liabilities	-	168.52	91.54	121.81	169.53	94.73
Long-Term Debt	-	8.77	33.35	26.82	14.33	25.97
Long-Term Deferred Tax Liabilities	-	0	-	-	-	-
Other Long-Term Liabilities	-	-0	0	0	-	-
Total Liabilities	-	177.29	124.89	148.63	183.86	120.69

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	40	40	40	40	40
Retained Earnings	-	3.59	-0.36	6.38	0.91	-5.08
Shareholders' Equity	43.59	43.59	39.64	46.38	40.91	34.93
Total Liabilities & Equity	-	220.87	164.53	195.01	224.77	155.62

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	101.92	101.92	86.52	51.7	79.97	55.08
Net Cash (Debt)	-101.27	-101.27	-85.35	-49.74	-78.27	-54.52
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-2.68	-2.53	-2.13	-1.27	-1.96	-1.36
Filing Date Shares Outstanding	36.68	40	40	40	40	40
Total Common Shares Outstanding	36.68	40	40	40	40	40
Working Capital	-	22.03	32.3	35.6	26.01	29.78
Book Value Per Share	1.06	1.09	0.99	1.16	1.02	0.87
Tangible Book Value	27.23	27.23	23.29	30.03	24.56	18.57
Tangible Book Value Per Share	0.66	0.68	0.58	0.75	0.61	0.46
Land	-	1.42	1.42	1.42	1.42	1.42
Buildings	-	2.46	2.46	2.46	2.46	2.46
Machinery	-	6.61	5.37	5.29	4.92	4.92

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 7, 2026

Data Sources Report a data error